Media Highlights
Contract Pharma: AbSci Acquires Cell Therapy Company Totient
Press Releases
AbSci Announces Acquisition of Target Discovery Company Totient
Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms
Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production
AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform
